Back to search

Finland· FI-REL-REL53788

PREVEXXION RN+HVT+IBD

A avian infectious bursal disease virus vaccine (gumboro disease) + avian herpes virus vaccine (marek's disease) product containing marek's disease virus, serotype 1, strain rn1250, live + turkey herpesvirus, strain vhvt013-69 (cell-associated), expressing vp2 protein gene of infectious bursal disease virus (strain faragher 52/70), live, registered in Finland by Boehringer Ingelheim Vetmedica GmbH. The same ATC class is registered in 2 of our 19 countries.

ATC QI01AD15

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedPREVEXXION RN+HVT+IBDATCQI01AD15REGISTER NO.FI-REL-REL53788PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Marek's disease virus, serotype 1, strain rn1250, live + turkey herpesvirus, strain vhvt013-69 (cell-associated), expressing vp2 protein gene of infectious bursal disease virus (strain faragher 52/70), live is registered in 2 of 19 countries.

Countries holding a registration under ATC QI01AD15 (avian infectious bursal disease virus vaccine (gumboro disease) + avian herpes virus vaccine (marek's disease)), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Marek's disease virus, serotype 1, strain rn1250, live + turkey herpesvirus, strain vhvt013-69 (cell-associated), expressing vp2 protein gene of infectious bursal disease virus (strain faragher 52/70), live · ATC QI01AD15

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Marek's disease virus, serotype 1, strain RN1250, Live + Turkey herpesvirus, strain vHVT013-69 (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus (strain Faragher 52/70), Live
Manufacturer
Boehringer Ingelheim Vetmedica GmbH
Country
Finland (FI)
ATC code
QI01AD15
ATC class
Avian infectious bursal disease virus vaccine (Gumboro disease) + Avian herpes virus vaccine (Marek's disease)
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/18c76ecd-c7cb-4e1c-bd63-0f48a70052c6
GET /v1/drugs/18c76ecd-c7cb-4e1c-bd63-0f48a70052c6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektiokonsentraatti ja liuotin, suspensiota varten",
  "route": "Ihon alle",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Avian infectious bursal disease virus vaccine (Gumboro disease) + Avian herpes virus vaccine (Marek's disease)",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/20/255/001-003",
  "fimea_rel_id": "REL53788",
  "authorised_at": "2020-07-20"
}

See everything about marek's disease virus, serotype 1, strain rn1250, live + turkey herpesvirus, strain vhvt013-69 (cell-associated), expressing vp2 protein gene of infectious bursal disease virus (strain faragher 52/70), live.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.